Dr. Hudis on Neoadjuvant Treatment of HER2-Positive Breast Cancer
2nd Annual Tatar Cancer Symposium 2012 - Dr HudisПодробнее
Dr. Clifford A. Hudis on In-Breast Response Rates in Triple-Negative Breast CancerПодробнее
Dr. Tolaney on the Neoadjuvant Therapy for HER2-Positive Breast CancerПодробнее
Neoadjuvant treatment approach for HER2 positive breast cancerПодробнее
Neoadjuvant Treatment Strategies for HER2-Positive Breast CancerПодробнее
Neoadjuvant Therapy for HER2-positive Breast Cancer - Dr. Scott ChristensenПодробнее
Dr. Pegram on Challenges in Neoadjuvant Treatment for HER2-Positive Breast CancerПодробнее
Dr. Hurvitz on Neoadjuvant Therapy for HER2+ Breast CancerПодробнее
HER2DX and pCR in HER2-positive breast cancer: a combined analysis of 4 neoadjuvant studiesПодробнее
Dr. Lori Goldstein on Neoadjuvant Treatment for HER2+ Breast CancerПодробнее
Dr. Hurvitz on Treatment Options for HER2-Positive Breast CancerПодробнее
An unanswerable question? Adjuvant and neoadjuvant treatment of breast cancerПодробнее
Optimizing adjuvant treatment in HR+/HER2- early breast cancerПодробнее
Overview of Neoadjuvant Therapy in HER2+ Breast CancerПодробнее
Dr. Tripathy on Neoadjuvant Treatment Strategies in HER2+ Breast CancerПодробнее
Next wave of successful drug therapy strategies in HER2-positive breast cancerПодробнее
Dr. Hurvitz on the Lack of Predictive Biomarkers in HER2+ Breast CancerПодробнее
Dr. Verma on Treatments in the Neoadjuvant Setting of HER2+ Breast CancerПодробнее
Dr. Ellis on Neoadjuvant Endocrine Therapy for Breast CancerПодробнее
